Portrait of David Buckeridge

David Buckeridge

Associate Academic Member

Full Professor, McGill University, Department of Epidemiology, Biostatistics and Occupational Health

Research Topics

Medical Machine Learning

Biography

David Buckeridge is a professor at the School of Population and Global Health at McGill University, as well as chief digital health officer for the McGill University Health Centre and executive scientific director of the Public Health Agency of Canada.

A Tier 1 Canada Research Chair in Health Informatics and Data Science, Buckeridge has projected health system demand for the Canadian province of Quebec, led data management and analytics for the Canadian Immunity Task Force, and supported the World Health Organization in monitoring global immunity to SARS-CoV-2. He has an MD from Queen's University, an MSc in epidemiology from the University of Toronto and a PhD in biomedical informatics from Stanford University. He is a Fellow of the Royal College of Physicians of Canada.

Current Students

Master's Research - McGill University

Master's Research - McGill University

PhD - McGill University

Master's Research - McGill University

yachen.li@mail.mcgill.ca

Master's Research - McGill University

Master's Research - McGill University

Master's Research - McGill University

Publications

BAND: Biomedical Alert News Dataset

Zihao Fu

Meiru Zhang

Zaiqiao Meng

Yannan Shen

Anya Okhmatovskaia

David Buckeridge

Nigel Collier

2024-01-01

AAAI (published)

Bidirectional Generative Pre-training for Improving Time Series Representation Learning

Ziyang Song

Qincheng Lu

He Zhu

David Buckeridge

2024-01-01

arXiv.org (preprint)

CODA: an open-source platform for federated analysis and machine learning on distributed healthcare data

Louis Mullie

Jonathan Afilalo

Patrick Archambault

Rima Bouchakri

Kip Brown

David Buckeridge

Yiorgos Alexandros Cavayas

Alexis F Turgeon

Denis Martineau

François Lamontagne

Martine Lebrasseur

Renald Lemieux

Jeffrey Li

Michaël Sauthier

Pascal St-Onge

An Tang

William Witteman

Michael Chassé

2023-12-21

J. Am. Medical Informatics Assoc. (published)

Extrapolatable Transformer Pre-training for Ultra Long Time-Series Forecasting

Ziyang Song

Qincheng Lu

Hao Xu

He Zhu

David Buckeridge

2023-11-29

ArXiv (preprint)

Estimating the population effectiveness of interventions against COVID-19 in France: a modelling study

Iris Ganser

David Buckeridge

Jane M. Heffernan

M. Prague

Rodolphe Thiébaut

Background Non-pharmaceutical interventions (NPIs) and vaccines have been widely used to manage the COVID-19 pandemic. However, uncertainty … (see more)persists regarding the effectiveness of these interventions due to data quality issues, methodological challenges, and differing contextual factors. Accurate estimation of their effects is crucial for future epidemic preparedness. Methods To address this, we developed a population-based mechanistic model that includes the impact of NPIs and vaccines on SARS-CoV-2 transmission and hospitalization rates. Our statistical approach estimated all parameters in one step, accurately propagating uncertainty. We fitted the model to comprehensive epidemiological data in France from March 2020 to October 2021. With the same model, we simulated scenarios of vaccine rollout. Results The first lockdown was the most effective, reducing transmission by 84% (95% confidence interval (CI) 83-85). Subsequent lockdowns had diminished effectiveness (reduction of 74% (69-77) and 11% (9-18), respectively). A 6pm curfew was more effective than one at 8 pm (68% (66-69) vs. 48% (45-49) reduction), while school closures reduced transmission by 15% (12-18). In a scenario without vaccines before November 2021, we predicted 159,000 or 194% (95% prediction interval (PI) 74-424) more deaths and 1,488,000 or 340% (136-689) more hospitalizations. If a vaccine had been available after 100 days, over 71,000 deaths (16,507-204,249) and 384,000 (88,579-1,020,386) hospitalizations could have been averted. Conclusion Our results highlight the substantial impact of NPIs, including lockdowns and curfews, in controlling the COVID-19 pandemic. We also demonstrate the value of the 100 days objective of the CEPI initiative for vaccine availability.

2023-09-14

medRxiv (preprint)

Impact of a vaccine passport on first-dose SARS-CoV-2 vaccine coverage by age and area-level social determinants of health in the Canadian provinces of Quebec and Ontario: an interrupted time series analysis

Jorge Luis Flores Anato

Huiting Ma

M. Hamilton

Yiqing Xia

Sam Harper

David Buckeridge

Marc Brisson

Michael P. Hillmer

Kamil A. Malikov

Aidin Kerem

Reed Beall

Caroline E Wagner

S. Baral

Étienne Racine

Ève Dubé

Sharmistha Mishra

Mathieu Maheu-Giroux

2023-09-01

CMAJ Open (published)

The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020–2023

Tanya J. Murphy

Hanna Swail

Jaspreet Jain

Maureen Anderson

Philip Awadalla

Lesley Behl

P. Brown

C. Charlton

Karen Colwill

S. Drews

A. Gingras

Deena Hinshaw

P. Jha

J. Kanji

Victoria A. Kirsh

Amanda Lang

Marc-andré Langlois

Stephen Lee

Antoine Lewin

Sheila F O’Brien … (see 10 more)

Chantale Pambrun

Kimberly Skead

David A. Stephens

Derek R. Stein

G. Tipples

Paul G. Van Caeseele

Timothy Grant Evans

Olivia Oxlade

Bruce D. Mazer

David Buckeridge

Background: During the first year of the COVID-19 pandemic, the proportion of reported cases of COVID-19 among Canadians was under 6%. Altho… (see more)ugh high vaccine coverage was achieved in Canada by fall 2021, the Omicron variant caused unprecedented numbers of infections, overwhelming testing capacity and making it difficult to quantify the trajectory of population immunity. Methods: Using a time-series approach and data from more than 900 000 samples collected by 7 research studies collaborating with the COVID-19 Immunity Task Force (CITF), we estimated trends in SARS-CoV-2 seroprevalence owing to infection and vaccination for the Canadian population over 3 intervals: prevaccination (March to November 2020), vaccine roll-out (December 2020 to November 2021), and the arrival of the Omicron variant (December 2021 to March 2023). We also estimated seroprevalence by geographical region and age. Results: By November 2021, 9.0% (95% credible interval [CrI] 7.3%–11%) of people in Canada had humoral immunity to SARS-CoV-2 from an infection. Seroprevalence increased rapidly after the arrival of the Omicron variant — by Mar. 15, 2023, 76% (95% CrI 74%–79%) of the population had detectable antibodies from infections. The rapid rise in infection-induced antibodies occurred across Canada and was most pronounced in younger age groups and in the Western provinces: Manitoba, Saskatchewan, Alberta and British Columbia. Interpretation: Data up to March 2023 indicate that most people in Canada had acquired antibodies against SARS-CoV-2 through natural infection and vaccination. However, given variations in population seropositivity by age and geography, the potential for waning antibody levels, and new variants that may escape immunity, public health policy and clinical decisions should be tailored to local patterns of population immunity.

2023-08-13

Canadian Medical Association Journal (published)

Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression

Niklas Bobrovitz

Harriet Ware

Xiaomeng Ma

Zihan Li

Reza Hosseini

Christian Cao

Anabel Selemon

Mairead Whelan

Zahra Premji

Hanane Issa

Brianna Cheng

Laith J Abu Raddad

David Buckeridge

Maria D Van Kerkhove

Vanessa Piechotta

Melissa M Higdon

Annelies Wilder-Smith

Isabel Bergeri

Daniel R Feikin

Rahul K. Arora … (see 2 more)

Minal K Patel

Lorenzo Subissi

2023-05-01

The Lancet Infectious Diseases (published)

Proactive Contact Tracing

Prateek Gupta

Martin Weiss

Nasim Rahaman

Hannah Alsdurf

Nanor Minoyan

Soren Harnois-Leblanc

Joanna Merckx

andrew williams

Victor Schmidt

Pierre-Luc St-Charles

Akshay Patel

Yang Zhang

David Buckeridge

Bernhard Schölkopf

2023-03-13

PLOS Digital Health (published)

A three-state coupled Markov switching model for COVID-19 outbreaks across Quebec based on hospital admissions (preprint)

Dirk Douwes-Schultz

Alexandra M. Schmidt

Yannan Shen

David Buckeridge

2023-02-05

ArXiv (preprint)

Applied artificial intelligence in healthcare: Listening to the winds of change in a post-COVID-19 world

Arash Shaban-Nejad

Martin Michalowski

Simone Bianco

John S. Brownstein

David Buckeridge

Robert L Davis

2022-11-25

Experimental Biology and Medicine (published)

Assessing the potential for virtualizable care in the pediatric emergency department.

Esli Osmanlliu

Brett Burstein

Robyn Tamblyn

David Buckeridge

INTRODUCTION There is increasing interest for patient-to-provider telemedicine in pediatric acute care. The suitability of telemedicine (vir… (see more)tualizability) for visits in this setting has not been formally assessed. We estimated the proportion of in-person pediatric emergency department (PED) visits that were potentially virtualizable, and identified factors associated with virtualizable care. METHODS This was a retrospective analysis of in-person visits at the PED of a Canadian tertiary pediatric hospital (02/2018-12/2019). Three definitions of virtualizable care were developed: (1) a definition based on "resource use" classifying visits as virtualizable if they resulted in a home discharge, no diagnostic testing, and no return visit within 72 h; (2) a "diagnostic definition" based on primary ED diagnosis; and (3) a stringent "combined definition" by which visits were classified as virtualizable if they met both the resource use and diagnostic definitions. Multivariable logistic regression was used to identify factors associated with telemedicine suitability. RESULTS There were 130,535 eligible visits from 80,727 individual patients during the study period. Using the most stringent combined definition of telemedicine suitability, 37.9% (95% confidence interval (CI) 37.6%-38.2%) of in-person visits were virtualizable. Overnight visits (adjusted odds ratio (aOR) 1.16-1.37), non-Canadian citizenship (aOR 1.10-1.18), ethnocultural vulnerability (aOR 1.14-1.22), and a consultation for head trauma (aOR 3.50-4.60) were associated with higher telemedicine suitability across definitions. DISCUSSION There is a high potential for patient-to-provider telemedicine in the PED setting. Local patient and visit-level characteristics must be considered in the design of safe and inclusive telemedicine models for pediatric acute care.

2022-11-20

Journal of Telemedicine and Telecare (published)